SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes pre-approval inspection at biologics manufacturing facility of Dr. Reddy's

13 Oct 2023 Evaluate

United States Food & Drug Administration (USFDA) has completed a product specific Pre-Approval Inspection (PAI) at Dr. Reddy's Laboratories’ biologics manufacturing facility in Bachupally, Hyderabad. The inspection was conducted from October 4, 2023 to October 12, 2023. The company has been issued a Form 483 with nine observations. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1241.10 -4.40 (-0.35%)
13-Jul-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.00
Dr. Reddys Labs. 1241.10
Cipla 1438.75
Zydus Lifesciences 1147.10
Lupin 2504.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: